| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Xenon Pharmaceuticals Inc. | Director | Common Shares | 6K | $59.1K | $9.85 | Jun 1, 2023 | Direct |
| Xenon Pharmaceuticals Inc. | Director | Stock Option (Right to Buy) | 18.5K | Jun 2, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| XENE | Xenon Pharmaceuticals Inc. | Jun 2, 2023 | 1 | $0 | 4 | Jun 2, 2023 | Director |
| XENE | Xenon Pharmaceuticals Inc. | May 30, 2023 | 19 | -$5.05M | 4 | Jun 1, 2023 | Director |
| XENE | Xenon Pharmaceuticals Inc. | Mar 7, 2023 | 8 | -$661K | 4 | Mar 9, 2023 | Director |
| XENE | Xenon Pharmaceuticals Inc. | Aug 12, 2022 | 6 | -$6.78M | 4 | Aug 16, 2022 | Director |
| XENE | Xenon Pharmaceuticals Inc. | Jun 28, 2022 | 1 | $0 | 4 | Jun 29, 2022 | Director |
| XENE | Xenon Pharmaceuticals Inc. | Mar 10, 2022 | 1 | $0 | 4 | Mar 14, 2022 | Executive Chair, Director |
| XENE | Xenon Pharmaceuticals Inc. | Mar 4, 2022 | 1 | -$77K | 4/A | Mar 8, 2022 | Director |
| XENE | Xenon Pharmaceuticals Inc. | Nov 15, 2021 | 1 | -$550K | 4 | Nov 16, 2021 | Director |
| XENE | Xenon Pharmaceuticals Inc. | May 24, 2021 | 3 | -$12.2K | 4 | May 26, 2021 | CEO, Director |